Thursday, April 12, 2018 10:14:26 AM
There's an ALLM ally posting here whose supporting "death spiral" /
toxic debt financing.
But if anyone wants to really know what's at stake, this scholarly
article shows that the shareholders are basically screwed:
<<V Managerial Motivations, Winners, Losers, and Remedies to Contract Design
Table II shows the largest investors in floating-priced convertibles. While the obvious gains from the issuance of death spiral convertibles accrue to the holders themselves, the losses are dispersed over multiple stakeholders. The biggest losers are usually the company's original creditors. If most of the issuing companies are destined for business demise anyway, then the company should probably terminate its life while assets remain to pay off existing debts. In reality, however, after the "death ride" is over, there is usually nothing left, and the creditors are left with nothing. The common shareholders also lose. In addition to the often calamitous amount of dilution they suffer, the possibility that their stock will be worthless is very real. Unfortunately, most companies do not inform their common shareholders of such deals until long after they have been struck and the toxics issued. There is no regulatory requirement that issuing companies must warn their shareholders of such deals beyond their regular SEC filings, particularly if the issuing company's shares are traded on the OTCBB or the Pink Sheets. Therefore, when a company issues toxics immediately after completing its regular filing, shareholders may well remain unaware until the firm's next filing, which could be three to five months later. By then, the stock price may have plummeted.>>
http://www.freepatentsonline.com/article/SAM-Advanced-Management-Journal/130469754.html
Recent BIOF News
- Form 8-K - Current report • Edgar (US Regulatory) • 01/24/2024 02:34:54 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 05:41:18 PM
- Form D/A - Notice of Exempt Offering of Securities: [Amend] • Edgar (US Regulatory) • 08/17/2023 01:26:03 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/07/2023 05:43:21 PM
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM